Professional Statements and Societal Positions Guidelines
Practice Guidelines and Position Statements
National Comprehensive Cancer Network
Primary Hepatobiliary Carcinoma
The NCCN guidelines (v.1.2019) on the treatment of hepatobiliary carcinoma indicate that the use of arterially directed therapies, including transarterial bland embolization, transarterial chemoembolization, and drug-eluting beads transarterial chemoembolization, and RE with yttrium-90 microspheres may be appropriate provided that the arterial blood supply can be isolated without excessive nontarget treatment.
Metastatic Neuroendocrine Tumors
The NCCN guidelines (v.2.2019) on the treatment of neuroendocrine tumors give a category 2B recommendation for hepatic regional therapy (arterial embolization, chemoembolization, RE) in the setting of advanced locoregional disease.
Metastatic Colon Cancer
The NCCN guidelines (v.2.2019) on the treatment of colon cancer provides a consensus recommendation that: "…arterial-directed catheter therapy, in particular yttrium-90 microsphere selective internal radiation, is an option in highly selected individuals with chemotherapy-resistant/-refractory disease and with predominant hepatic metastases."